Important: The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, blogs, or WebMD Answers are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatments or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service, or treatment. Do not consider WebMD User-generated content as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.
Unless the immune system is compromised, it suppresses reactivation of the virus and prevents shingles outbreaks. Why this suppression sometimes fails is poorly understood, but shingles is more likely to occur in people whose immune systems are impaired due to aging, immunosuppressive therapy, psychological stress, or other factors. Upon reactivation, the virus replicates in neuronal cell bodies, and virions are shed from the cells and carried down the axons to the area of skin innervated by that ganglion. In the skin, the virus causes local inflammation and blistering. The short- and long-term pain caused by shingles outbreaks originates from inflammation of affected nerves due to the widespread growth of the virus in those areas.
RZV is currently licensed for all persons 50 years of age and older. Immunosuppression is not included as a contraindication in the manufacturers’ package insert. However, immunocompromised persons and those on moderate to high doses of immunosuppressive therapy were excluded from the clinical efficacy studies so data are lacking on efficacy and safety in this group. ACIP has not made a recommendation regarding the use of RZV in these patients. This topic is anticipated to be discussed at upcoming ACIP meetings as additional data become available.
Any unusual condition, such as a severe allergic reaction or a high fever. If a severe allergic reaction occurred, it would be within a few minutes to an hour after the shot. Signs of a serious allergic reaction can include difficulty breathing, hoarseness or wheezing, swelling of the throat, hives, paleness, weakness, a fast heart beat, or dizziness.
ACIP does not have a recommendation to administer either zoster vaccine to people younger than 50 years with recurrent zoster episodes. However, clinicians may choose to administer a vaccine off-label, if in their clinical judgment, they think the vaccine is indicated. The patient should be informed that the use is off-label, and that the safety and efficacy of the vaccine has not been tested in people younger than 50.
The shingles rash is contagious (for someone else to catch chickenpox) until all the blisters (vesicles) have scabbed and are dry. If the blisters are covered with a dressing, it is unlikely that the virus will pass on to others. This is because the virus is passed on by direct contact with the blisters. If you have a job, you can return to work once the blisters have dried up, or earlier if you keep the rash covered and feel well enough. Similarly children with shingles can go to school if the rash is covered by clothes and they do not feel unwell.
^ Han, Y; Zhang, J; Chen, N; He, L; Zhou, M; Zhu, C (Mar 28, 2013). “Corticosteroids for preventing postherpetic neuralgia”. Cochrane Database of Systematic Reviews. 3 (3): CD005582. doi:10.1002/14651858.CD005582.pub4. PMID 23543541.
“About one in three people who develop shingles may continue to suffer from chronic pain six months after the initial illness. We call this prolonged pain, known as PHN. This chronic pain is debilitating and can lead to other consequences like sleeping problems, depression and social withdrawal,” Pearl said.
^ a b c Pollak, L; Dovrat, S; Book, M; Mendelson, E; Weinberger, M (August 2011). “Varicella zoster vs. herpes simplex meningoencephalitis in the PCR era. A single center study”. Journal of the Neurological Sciences. 314 (1–2): 29–36. doi:10.1016/j.jns.2011.11.004. PMID 22138027.
“But, with time and as one gets older, there is a decline in natural immunity and the virus can flair up again, presenting as shingles,” Glass said. Consequently, the risk of shingles increases as one gets older and the likelihood of persistent pain increases dramatically after the age of 50.
Viral infections cause significant disease and even death in patients with blood cancers. In the current systematic review of randomized controlled trials (RCTs) we aimed to evaluate the efficacy and safety of viral vaccines in these patients. The pre-defined primary outcome was incidence of the infection concerned. Secondary outcomes were mortality due to the viral infection, all-cause mortality, incidence of complications, incidence of severe viral infection, hospitalization rate, in vitro immune response and frequency of adverse effects. Eight RCTs were included. They evaluated heat-inactivated varicella zoster virus (VZV) vaccine (two trials), influenza vaccines (five trials) and inactivated poliovirus vaccine (one trial). There were no RCTs on other viral vaccines (hepatitis A, hepatitis B, measles, mumps, rubella). Only the two trials on VZV vaccine reported our pre-defined primary outcome. All trials reported some of the pre-defined secondary outcomes. We found that inactivated VZV vaccine might reduce the severity of herpes zoster when given before and after stem cell transplant in adults with lymphoma or leukemia. Inactivated influenza vaccine might reduce upper and lower respiratory infections and hospitalization in adults with multiple myeloma who are undergoing chemotherapy, or children with leukemia or lymphoma within two years post-chemotherapy. However, the quality of evidence is not high. Local adverse effects occur frequently with the vaccines, although serious adverse effects appear uncommon. Further high-quality RCTs are needed to clarify the benefits and optimal regimens of viral vaccines for patients with blood cancers.
To prevent shingles, adults who are 60 years old and older should receive the shingles vaccine. To relieve pain, you can apply a cool washcloth to the blisters. Keep the rash covered as much as possible to avoiding spreading the varicella virus to others. Ask your doctor if you’re a candidate for anti-viral medications, which can reduce the length and intensity of the virus. You doctor can also prescribe pain medications if necessary.
Fibre (fiber) cement shingles are often known by their manufacturer’s name such as eternit or transite. Sometimes the fiber in the cement material was asbestos which has been banned for health reasons since the 1980s. Removal of asbestos shingles requires extra precautions and disposal methods.
But because the new shingles vaccine contains a nonliving viral particle, it may ultimately be deemed appropriate for those with compromised immunity. (Zostavax contains live—although weakened—herpes zoster virus, so those with significantly weakened immune systems should not receive it.) The ACIP will review data on Shingrix in these groups as it becomes available.
“Patients and health care providers should be aware that this vaccine is very effective, but it also causes more reactions than they may be used to with other adult vaccines,” she said. “All indications are these are not dangerous to one’s health, but they may interfere with your daily activities for a few days.”
Symptoms of shingles affect the nerves and the skin and can occur in almost any part of the body. However, shingles most often affects one side of the trunk. Symptoms generally begin with sensations of itching, tingling, and/or a severe burning pain in the affected area. The pain can be severe. Several days later a rash develops in a band or patch-like shape. Other symptoms can include fever, headache, and chills.
^ Grahn, A; Studahl, M (September 2015). “Varicella-zoster virus infections of the central nervous system – Prognosis, diagnostics and treatment”. Journal of Infection. 71 (3): 281–93. doi:10.1016/j.jinf.2015.06.004. PMID 26073188.
Zostavax has been shown to offer protection against shingles for about five years. Although Zostavax is approved for people age 50 and older, the Centers for Disease Control and Prevention isn’t recommending it until you reach age 60, when the risk of shingles and its complications is highest. Studies suggest protection from Shingrix may extend beyond five years. Shingrix is approved and recommended for people age 50 and older, including those who’ve previously received Zostavax.
Shingles can affect any part of the body, including the face. Classically, the rash caused by shingles often takes the shape of a belt from the midline on one side of the body. The rash forms its characteristic pattern because the virus works down the nerves that branch out from the spinal cord. The chest and lumbar region are most commonly affected.
In studies, most older recipients said they’d experienced pain, redness or swelling in their upper arms for a day or two after the shot, and 8.5 percent of those over age 70 deemed those symptoms uncomfortable enough to interfere with normal activities.
You can take steps to reduce the duration of a shingles outbreak, but in the end, the virus must often simply run its course. There is no cure for shingles. Antiviral medication is effective only if given early, so it is important to visit your doctor soon after an outbreak starts or is suspected Those with facial, nose, or eye symptoms should seek medical care immediately. Early medical attention may also prevent or reduce any scarring.
It’s uncommon (though not unheard of) for shingles to affect the external area around the called the vulva. It’s very unusual for shingles to affect the inside of the vagina itself, but it can occur.
The only real way to prevent someone getting shingles is for them to have had the vaccine for chickenpox. In South Africa, this vaccine is given as part of the South African vaccination schedule. However, the vaccine, if given in adulthood, may also reduce the effects of shingles and is therefore recommended for people of 60 and over.
In addition, anyone who was eligible for immunisation in the previous three years of the programme but missed out on their shingles vaccination remains eligible until their 80th birthday. This includes:
I was wondering why the vaccination is only recommended for ages younger than 60. I understand the older in age the greater the risk of getting shingles but I have only known of two people ever getting shingles and they were infected before the age of 50.